Digestive programs are leaking value—25–30% of GI incidental findings never reach resolution. If you can’t prove closure, you’re losing it.
#ThynkHealth #HealthcareAutomation #DigestiveHealth #CancerPrograms 🚀
19
ER tracking programs are leaking value—less than 50% of ED findings get documented follow-up. If you can’t prove closure, you’re losing it.
#ThynkHealth #HealthcareAutomation #ERTracking #CancerPrograms 🚀
7
GU programs are leaking value—22–33% of renal masses lack documented follow-up. If you can’t prove closure, you’re losing it.
#ThynkHealth #HealthcareAutomation #GU #CancerPrograms 🚀
23
Endocrine programs are leaking value—28% of adrenal nodules miss follow-up. If you can’t prove closure, you’re losing it.
#ThynkHealth #HealthcareAutomation #Endocrine #CancerPrograms 🚀
19
Cardiovascular programs are leaking value—up to 35% of findings go unresolved. If you can’t prove closure, you’re losing it.
#ThynkHealth #HealthcareAutomation #Cardiovascular #CancerPrograms 🚀
14
ER findings only matter if they reach resolution.
Dashboards track tasks. Automation closes loops.
#ThynkHealth #HealthcareAutomation #EmergencyDepartment #CancerPrograms #AIinHealthcare
11
27% of incidental ovarian findings lack longitudinal tracking. That’s not an operational miss — that’s clinical risk and revenue leakage. Most systems track activity. Thynk Health proves resolution. #WomensHealth #CancerPrograms #HealthcareAutomation #HealthSystemLeadership
8
Dashboards don’t create accountability — and worklists don’t escalate risk. If 25% of 350 renal mass cases miss follow-up at $1,600 each, that’s $140,000 slipping through the cracks.
That’s not strategy. That’s exposure.
We don’t track tasks — we guarantee resolution.
#GUHealth
9
🔥 28% of adrenal nodules miss interval imaging compliance.
That’s not a workflow gap — that’s clinical, financial, and reputational exposure. Tracking isn’t enough. Automation ensures action. #EndocrineHealth #HealthcareAutomation #HealthSystemLeadership #ThynkHealth 🚀
19
Nearly 30% of liver lesion surveillance falls outside guideline intervals. That’s not inefficiency — that’s uncontrolled risk. If you can’t prove documented resolution, you don’t control your liver program — you have exposure. Hope isn’t a strategy. Automation is. #LiverHealth
14
Digestive: 25–30% of GI incidental findings never reach documented resolution. Dashboards track tasks. Automation closes loops. #ThynkHealth 🚀
19
Cardiovascular: Up to 35% of incidental cardiac findings lack structured follow-up. Dashboards track tasks. Automation closes loops. #ThynkHealth 🚀
15
Pulmonary: Dashboards measure activity. Automation guarantees resolution. Infrastructure wins. #ThynkHealth 🚀
19
🎁 WIN a Ritz-Carlton Spa Day — ACE 2026 🎁
Attending Association of Cancer Executives Annual Meeting?
📍 Booth 106 = extra entry (double your odds)
Enter now 👉 thynkhealth.com/ace-giveaway…
#ACE2026 #Giveaway #HealthIT
35
Most companies talk about “improving outcomes.”
We prove it.
📈 Baseline screening climbs
📈 Annual volumes compound
📈 Follow-ups explode once patients stop disappearing
This isn’t growth theater.
It’s what happens when early detection actually gets managed.
Results compound.
22
Our SVP of Sales, Rob Hamilton, has been appointed to the American Lung Association Board (Gulf Coast, FL).
With 30+ years in healthcare IT and deep leadership in early detection + lung cancer screening, Rob will be a fantastic addition to the board.
Proud to have him on our team
1
29
Thynk Health is heading to Charlotte for the Advocate Health Pulmonary Oncology 2025 Summit!
Join us Nov 7–8 as we connect with leaders in lung cancer care and precision screening innovation.
#ThynkHealth #PulmonaryOncology #LungCancer #AIinHealthcare
16
We’re heading to New Orleans for the AONN+ 2025 Annual Conference! 🎉
Catch Thynk Health’s Kim Parham, BSN, RN speaking Friday morning on Lung Cancer Screening & Updated Guidelines.
Let’s connect while you’re there!
#AONN2025 #ThynkHealth #CancerScreening #OncologyInnovation
86



















